Review: Risks and benefits of HRT comparing various sources of evidence
- Review: Observational studies adjusting for socioeconomic status and lifestyle show no association between HRT and CAD. Colditz, Graham // ACP Journal Club;Mar/Apr2003, Vol. 138 Issue 2, p40
Examines the effectiveness of postmenopausal hormone replacement therapy for prevention of cardiovascular disease. Sources of data used in the study; Role of estrogens in atherogenesis.
- GPs left in confusion as experts battle over HRT. Gough, Rob // Pulse;11/4/2002, Vol. 62 Issue 42, p2
Focuses on the conflict between medical experts over the effect of hormone replacement therapy on cardiovascular disease in Great Britain. Statement issued by the government's Committee on the Safety of Medicines regarding the need for general practitioners to stop prescribing HRT for the...
- A combo of estrogen and progesterone does protect the heart. Cerrato, Paul L. // RN;Feb97, Vol. 60 Issue 2, p75
Presents information from the article entitled `Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease' by F. Grodstein, M.J. Stampfer, et al published in the 335th edition of the `New England Journal of Medicine.'
- Cardiovascular benefits of HRT may differ by patient age. Rosano, Giuseppe; Vitale, Cristiana // Evidence Based Medicine;Apr2014, Vol. 19 Issue 2, p61
The authors' discuss a study by C. Main and colleagues regarding the negative risk or benefit of hormone replacement therapy (HRT) in preventing cardiovascular disease (CVD) in post-menopausal women. Topics include the use of a meta-analysis of randomised controlled trials (RCTs), the clinical...
- Postmenopausal Hormone Replacement Therapy: How Could We Have Been So Wrong? Laine, Christine // Annals of Internal Medicine;8/20/2002, Vol. 137 Issue 4, p290
Editorial. Explores issues associated with postmenopausal hormone replacement therapy (HRT) in women in the U.S. Reduction in the risk of coronary events in women who took HRT after menopause; Association between risk of cardiovascular disease and socioeconomic status; U.S. Preventive Services...
- The Heart of the Matter. Swetlikoff, Garrett // Alive: Canada's Natural Health & Wellness Magazine;Feb2003, Issue 244, p37
Identifies the risk factors of cardiovascular disease and the possibility of disease prevention. Age; Difference of disease development between men and women; Family history; Tobacco smoking; Physical inactivity; Diabetes; Excessive alcohol use.
- PERCEPCIONES, ACTITUDES Y CONDUCTAS DE MÃ‰DICOS GINECO-OBSTETRAS, RESPECTO AL USO ACTUAL DE TERAPIA DE REEMPLAZO HORMONAL. Pizarro, O. Ernesto; C. Mauricio Villarroel; Fertilio, T. Oscar; Gadán, H. Ana; González, V. Marcelo; Ibarra, P. Agustín; Parra, A. Manuel; Riveros, K. Rodrigo; Sandoval, S. César; Silva, R. Patricio; Valverde, P. Victor // Revista Chilena de Obstetricia y GinecologÃa;2008, Vol. 73 Issue 1, p11
In order to set a diagnosis about the use of hormonal replacement therapy (HRT) in pen and postmenopausal women by the obstetricians and gynecologists members of our staff, we did a survey that was answered by 97.6% of them. Questions about the future patients desire related to use of HRT or use...
- The role of HRT: where are we now? Clinical implications of latest HRT data. Currie, Heather // Journal of the British Menopause Society;2003 Supplement, Vol. 9, p10
The results of the Women's Health Initiative have highlighted some small but important risks associated with hormone replacement therapy (HRT). Interpretation of these findings by the media has generated considerable adverse publicity. This review discusses the clinical implications of recent...
- Postmenopausal Hormone Replacement Therapy and the Primary Prevention of Cardiovascular Disease. Humphrey, Linda L.; Chan, Benjamin K.S.; Sox, Harold C. // Annals of Internal Medicine;8/20/2002, Vol. 137 Issue 4, p273
Provides a study regarding the value of hormone replacment therapy (HRT) as the primary prevention of cardiovascular disease and coronary heart disease. Reviews past studies and rates for quality; Concludes there is need for more randomized controlled trials.